CME restriction bid rebuffed, again

A third attempt by an AMA ethics council asking physicians and medical institutions to curb industry funding for professional educational activities was rebuffed last month.

The proposals, contained in a report from AMA's Council on Ethical and Judicial Affairs (CEJA), would have required CME providers to only accept funds from “sources that have no direct financial interest in a physician's clinical recommendations,” except in certain cases. At the AMA's semi-annual policymaking meeting, its House of Delegates voted to send the entire report back to CEJA for further study.

“The rejection by the House of Delegates shows a commitment to CME funding and academic freedom,” wrote Rockpointe president Thomas Sullivan in the blog Policy and Medicine.

At a committee meeting prior to the vote, 25 speakers representing 24 organizations spoke against adoption of the CEJA recommendations, according to Sullivan, while in favor were 10 speakers representing CEJA, the AMA's Council on Medical Education and other organizations.

The last time delegates sent a CEJA proposal back to committee was in June. That proposal sought to delineate “ethically preferable” or “ethically permissible” CME funding practices. A 2008 proposal—also shelved—had called for an all-out ban on commercial support.

In a statement, AMA chair Dr. Rebecca Patchin said CEJA “will re-examine the issue and present a revised report at a later meeting.”
You must be a registered member of MMM to post a comment.

Next Article in Features

Content marketing is not advertising in the old sense. In its use of social media, content marketing challenges consumers while relying on their input. It is proactive and responsive to their concerns, needs and energy. Content marketing has become the new voice of marketing. Learn what you need to know and how pharma marketers can adapt to this innovative venture into social media by clicking here for access.

Email Newsletters